WASHINGTON, Aug. 23, 2019 /PRNewswire/ -- Researchers at the U.S. Naval Research Laboratory have identified a new algorithm that could help virologists better understand and treat infections caused by viruses like the Zika virus.

EXTON, Pa., Aug. 23, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, to

STOCKHOLM, Sweden, Aug. 23, 2019 /PRNewswire/ -- OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), today announced that, based on a positive opinion from the Paediatric Committee (PDCO), the EMA has agreed to the proposed PIP for Oxalobacter formigenes in the treatment of primary hype

SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting) has accepted three abstracts on the clinical trials of CS1001 (Anti-PD-L1 antibody), CS1002 (Anti-CTLA-4 antibody), and CS1003 (Anti-PD-1 antib

SUZHOU, China, Aug. 22, 2019 /PRNewswire/ --  CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received ethics approval from the Human Research Ethics Committee in Australia for the Phase I clinical trial of CS3002, and Australia's Therapeuti

INDIANAPOLIS, Aug. 22, 2019 /PRNewswire/ -- A Chicago-based arbitration panel has ruled in favor of Eli Lilly and Company (NYSE: LLY) in a claim filed by Adocia S.A. over the companies' prior collaboration on a rapid-acting insulin. The panel of three arbitrators ruled that Lilly acted appropriately regarding Adocia's intellectual property, and while they denied Lil

BRENTWOOD, Tenn., Aug. 22, 2019 /PRNewswire/ -- AAC Holdings, Inc. (NYSE: AAC) (the "Company") announced that the Company received a written notice (the "Notice") from the New York Stock Exchange (the "NYSE") indicating that the Company is not in compliance with the NYSE's continued listing requirements under the timely filing criteria outlined in Section 802.01E of

In the news release, EW Healthcare Partners Raises Over $745 Million Fund 2a, issued 22-Aug-2019 by EW Healthcare Partners over PR Newswire, we are advised by the company that the headline and first paragraph should read "Fund 2" rather than "Fund 2a" as originally issued inadvertently. The complete, corrected release follows:EW Healthcare Partners Raises Over $745

BIRMINGHAM, Ala., Aug. 22, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to expand its network of hospitals through the addition of a 50-bed inpatient rehabilitation hospital in Cumming, Georgia.

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- This month Marijuanadoctors.com celebrates 10 years as the trusted resource for consumers & physicians in the medical marijuana industry. The MarijuanaDoctors.Com platform has pioneered the medical marijuana market while connecting more than 40 percent of the medical marijuana patient population. MarijuanaDoctors.Com provides p